As recommended and approved by the board, the pharma company will be paying an interim dividend of Rs 1.25 (62.5%) per equity share of Rs 2 each for the financial year 2018.
In the same meeting, the company also scheduled the date for the annual general meeting of the company as September 23, 2017.
Hyderabad-headquartered Natco Pharma had recently received an establishment inspection report (EIR) from the US Food and Drugs Association (USFDA) for its Kothur manufacturing facility at Telangana.
Natco Pharma Ltd is currently trading at Rs 952.55, up by Rs 3.35 or 0.35% from its previous closing of Rs 949.2 on the BSE.
The scrip opened at Rs 950 and has touched a high and low of Rs 986.55 and Rs 932.4 respectively. So far 701690(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 16545.3 crore.
The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1080 on 09-Jun-2017 and a 52 week low of Rs 495 on 09-Nov-2016. Last one week high and low of the scrip stood at Rs 987.3 and Rs 936.8 respectively.
The promoters holding in the company stood at 51.16 % while Institutions and Non-Institutions held 27.06 % and 21.78 % respectively.
The stock is currently trading below its 50 DMA.
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.
- Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
- Now Save Rs.3150 on your Demat Account ...Click here
- Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
- Get the most detailed result analysis on the web - Real Fast!
- Actionable & Award-Winning Research on 500 Listed Indian Companies.